The Effect of Sodium Hyaluronate Eye Drops 2, 4 or 6 Times a Day on Signs and Symptoms of Dry Eye Disease

References

• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
   PubMed Web of Science ®Google Scholar
• Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.003
   PubMed Web of Science ®Google Scholar
• Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100(3):300–306. doi:10.1136/bjophthalmol-2015-307415
   PubMed Web of Science ®Google Scholar
• Gagliano C, Caruso S, Napolitano G, et al. Low levels of 17-β-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: a case–control study. Br J Ophthalmol. 2014;98(3):371–376. doi:10.1136/bjophthalmol-2012-302705
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Rocha EM, Aragona P, et al. TFOS DEWS II Sex, Gender, and Hormones Report. Ocul Surf. 2017;15(3):284–333. doi:10.1016/j.jtos.2017.04.001
   PubMed Web of Science ®Google Scholar
• Warren DW, Azzarolo AM, Huang ZM, et al. Androgen Support of Lacrimal Gland Function in the Female Rabbit. Int J Med. 1998:89–93. doi:10.1007/978-1-4615-5359-5_11
   Google Scholar
• Versura P, Giannaccare G, Campos EC. Sex-Steroid Imbalance in Females and Dry Eye. Curr Eye Res. 2015;40(2):162–175. doi:10.3109/02713683.2014.966847
   PubMed Web of Science ®Google Scholar
• Weng J, Fink MK, Sharma A. A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations. Int J Mol Sci. 2023;24(3):2758. doi:10.3390/ijms24032758
   PubMed Web of Science ®Google Scholar
• Kathuria A, Shamloo K, Jhanji V, Sharma A. Categorization of Marketed Artificial Tear Formulations Based on Their Ingredients: a Rational Approach for Their Use. J Clin Med. 2021;10(6):1289. doi:10.3390/jcm10061289
   PubMed Web of Science ®Google Scholar
• You IC, Li Y, Jin R, Ahn M, Choi W, Yoon KC. Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye. J Ocular Pharmacol Therapeutics. 2018;34(8):557–564. doi:10.1089/jop.2018.0032
   PubMed Web of Science ®Google Scholar
• Pisárčik M, Bakoš D, Čeppan M. Non-Newtonian properties of hyaluronic acid aqueous solution. Colloids Surf a Physicochem Eng Asp. 1995;97(3). doi:10.1016/0927-7757(95)03097-W
   Web of Science ®Google Scholar
• Walsh K, Jones L. The use of preservatives in dry eye drops. Clin Ophthalmol. 2019;13. doi:10.2147/OPTH.S211611
   PubMed Web of Science ®Google Scholar
• Ribeiro MVMR, Barbosa FT, Ribeiro LEF, Sousa-Rodrigues CF, Ribeiro EAN. Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review. Arq Bras Oftalmol. 2019;82(5). doi:10.5935/0004-2749.20190097
   Web of Science ®Google Scholar
• Szczesna-Iskander DH, Muzyka-Wozniak M, Llorens Quintana C. The efficacy of ocular surface assessment approaches in evaluating dry eye treatment with artificial tears. Sci Rep. 2022;12(1):21835. doi:10.1038/s41598-022-26327-3
   PubMed Web of Science ®Google Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II Management and Therapy Report. Ocular Surface. 2017;15(3). doi:10.1016/j.jtos.2017.05.006
   Web of Science ®Google Scholar
• Rodriguez-Garcia A, Babayan-Sosa A, Ramirez-Miranda A, et al. A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: a Proposal from the Mexican Dry Eye Disease Expert Panel. Clin Ophthalmol. 2022;16:1331–1355. doi:10.2147/OPTH.S351898
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocular Surface. 2017;15(3). doi:10.1016/j.jtos.2017.05.001
   Web of Science ®Google Scholar
• Akpek EK, Amescua G, Farid M, et al. Dry Eye Syndrome Preferred Practice Pattern®. Ophthalmology. 2019;126(1):286–P334. doi:10.1016/j.ophtha.2018.10.023
   PubMed Web of Science ®Google Scholar
• Bron AJ. Methodologies to Diagnose and Monitor Dry Eye Disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):108–152. doi:10.1016/S1542-0124(12)70083-6
   PubMed Web of Science ®Google Scholar
• Bron AJ, Evans VE, Smith JA. Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests. Cornea. 2003;22(7):640–650. doi:10.1097/00003226-200310000-00008
   PubMed Web of Science ®Google Scholar
• Eom Y, Lee JS, Keun Lee H, Myung Kim H, Suk Song J. Comparison of conjunctival staining between lissamine green and yellow filtered fluorescein sodium. Canadian J Ophthalmol. 2015;50(4):273–277. doi:10.1016/j.jcjo.2015.05.007
   PubMed Web of Science ®Google Scholar
• Singh RB, Liu L, Anchouche S, et al. Ocular redness – I: etiology, pathogenesis, and assessment of conjunctival hyperemia. Ocul Surf. 2021;21:134–144. doi:10.1016/j.jtos.2021.05.003
   PubMed Web of Science ®Google Scholar
• Efron N. Grading scales for contact lens complications. Ophthalmic Physiological Optics. 1998;18(2):182–186. doi:10.1016/S0275-5408(97)00066-5
   PubMed Web of Science ®Google Scholar
• Dang TT, Nguyen TH, Ho TB. Causality Assessment of Adverse Drug Reaction: controlling Confounding Induced by Polypharmacy. Curr Pharm Des. 2019;25(10):1134–1143. doi:10.2174/1381612825666190416115714
   PubMed Web of Science ®Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi:10.1038/clpt.1981.154
   PubMed Web of Science ®Google Scholar
• Armstrong RA, Davies LN, Dunne MCM, Gilmartin B. Statistical guidelines for clinical studies of human vision. Ophthalmic Physiological Optics. 2011;31(2):123–136. doi:10.1111/j.1475-1313.2010.00815.x
   PubMed Web of Science ®Google Scholar
• Karakosta A, Vassilaki M, Plainis S, Elfadl NH, Tsilimbaris M, Moschandreas J. Choice of Analytic Approach for Eye-Specific Outcomes: one Eye or Two? Am J Ophthalmol. 2012;153(3):571–579.e1. doi:10.1016/j.ajo.2011.08.032
   PubMed Web of Science ®Google Scholar
• Armstrong RA. Statistical guidelines for the analysis of data obtained from one or both eyes. Ophthalmic Physiological Optics. 2013;33(1):7–14. doi:10.1111/opo.12009
   PubMed Web of Science ®Google Scholar
• Pinto-Fraga J, López-de la Rosa A, Blázquez Arauzo F, Urbano Rodríguez R, González-García MJ. Efficacy and Safety of 0.2% Hyaluronic Acid in the Management of Dry Eye Disease. Eye Contact Lens. 2017;43(1):57–63. doi:10.1097/ICL.0000000000000236
   PubMed Web of Science ®Google Scholar
• Chow SC, Wang H, Shao J. Sample Size Calculations in Clinical Research. Chapman and Hall/CRC; 2007; doi:10.1201/9781584889830
   Google Scholar
• Bartlett J, Keith M, Sudharshan L, Snedecor S. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol. 2015;1719. doi:10.2147/OPTH.S89700
   PubMedGoogle Scholar
• Abatangelo G, Vindigni V, Avruscio G, Pandis L, Brun P. Hyaluronic Acid: redefining Its Role. Cells. 2020;9(7):1743. doi:10.3390/cells9071743
   PubMed Web of Science ®Google Scholar
• Liao YH, Jones SA, Forbes B, Martin GP, Brown MB. Hyaluronan: pharmaceutical Characterization and Drug Delivery. Drug Deliv. 2005;12(6):327–342. doi:10.1080/10717540590952555
   PubMed Web of Science ®Google Scholar
• Asbell P, Vingrys AJ, Tan J, et al. Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: a 6-Week, Observer-Masked Phase 4 Clinical Trial. Investigative Ophthalmol Visual Sci. 2018;59(6):2275. doi:10.1167/iovs.17-23733
   PubMed Web of Science ®Google Scholar
• Baiza-Durán LM, Muñoz-Villegas P, Sánchez-Ríos A, Olvera-Montaño O. Efficacy and Safety of an Ophthalmic DMPC-Based Nanoemulsion in Patients with Dry Eye Disease: a Phase I/II Randomized Clinical Trial. J Ophthalmol. 2023;2023:1–9. doi:10.1155/2023/1431473
   Web of Science ®Google Scholar
• Pucker AD, Ng SM, Nichols JJ. Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Sys Rev. 2016;2016(2). doi:10.1002/14651858.CD009729.pub2
   Google Scholar
• Nichols KK, Mitchell GL, Zadnik K. The Repeatability of Clinical Measurements of Dry Eye. Cornea. 2004;23(3):272–285. doi:10.1097/00003226-200404000-00010
   PubMed Web of Science ®Google Scholar
• Johnson ME. The Association Between symptoms of Discomfort and signs in Dry Eye. Ocul Surf. 2009;7(4):199–211. doi:10.1016/S1542-0124(12)70187-8
   PubMed Web of Science ®Google Scholar
• Sullivan DA, Jensen RV, Suzuki T, Richards SM. Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands? Mol Vis. 2009;15:1553–1572.
   PubMed Web of Science ®Google Scholar
• Schirra F, Suzuki T, Richards SM, et al. Androgen Control of Gene Expression in the Mouse Meibomian Gland. Investigative Ophthalmol Visual Sci. 2005;46(10):3666. doi:10.1167/iovs.05-0426
   PubMed Web of Science ®Google Scholar
• Truong S, Cole N, Stapleton F, Golebiowski B. Sex hormones and the dry eye. Clin Exp Optom. 2014;97(4):324–336. doi:10.1111/cxo.12147
   PubMed Web of Science ®Google Scholar
• Suzuki T, Kinoshita Y, Tachibana M, et al. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res. 2001;22(1):28–33. doi:10.1076/ceyr.22.1.28.6980
   PubMed Web of Science ®Google Scholar
• Wróbel-Dudzińska D, Osial N, Stępień PW, Gorecka A, Żarnowski T. Prevalence of Dry Eye Symptoms and Associated Risk Factors among University Students in Poland. Int J Environ Res Public Health. 2023;20(2):1313. doi:10.3390/ijerph20021313
   PubMed Web of Science ®Google Scholar
• Sharma A, Porwal S, Tyagi M. Effect of oral contraceptives on tear film in reproductive age group women. Int J Reprod Contracept Obstet Gynecol. 2018;7(3):860. doi:10.18203/2320-1770.ijrcog20180410
   Google Scholar
• Boga A, Stapleton F, Briggs N, Golebiowski B. Daily fluctuations in ocular surface symptoms during the normal menstrual cycle and with the use of oral contraceptives. Ocul Surf. 2019;17(4):763–770. doi:10.1016/j.jtos.2019.06.005
   PubMed Web of Science ®Google Scholar
• Ang BCH, Sng JJ, Wang PXH, Htoon HM, Tong LHT. Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: a Systematic Review and Meta-Analysis. Sci Rep. 2017;7(1):9013. doi:10.1038/s41598-017-08534-5
   PubMed Web of Science ®Google Scholar
• Yang YJ, Lee WY, jin KY. A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome. Int J Environ Res Public Health. 2021;18(5):2383. doi:10.3390/ijerph18052383
   PubMed Web of Science ®Google Scholar
• Johnson ME, Murphy PJ, Boulton M. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye. Graefe’s Arch Clin Exp Ophthalmol. 2006;244(1):109–112. doi:10.1007/s00417-005-0028-1
   PubMed Web of Science ®Google Scholar
• Abdelfattah NS, Dastiridou A, Sadda SR, Lee OL. Noninvasive Imaging of Tear Film Dynamics in Eyes With Ocular Surface Disease. Cornea. 2015;34(Supplement 10):S48–S52. doi:10.1097/ICO.0000000000000570
   PubMedGoogle Scholar